$BHVN 8-K SEC Filings

Filed On	Filing
22 Oct 2026	8-K: Regulation FD Disclosure On October 22, 2026, Biohaven Ltd. (the Company) provided an update on the spinocerebeller ataxia (SCA) program.
15 Oct 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) the type of information that the registrant customarily and actually treats as private or confidential. Excluded information ...
10 Sep 2026	8-K: Other Events Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
26 Aug 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
10 Aug 2026	8-K: Results of Operations and Financial Condition
07 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation
09 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation
27 May 2026	8-K: Regulation FD Disclosure
05 May 2026	8-K: Other Events
04 May 2026	8-K: Results of Operations and Financial Condition
04 May 2026	8-K: Submission of Matters to a Vote of Security Holders
02 Mar 2026	8-K: Results of Operations and Financial Condition
12 Jan 2026	8-K: Regulation FD Disclosure
07 Jan 2026	8-K: Other Events
13 Nov 2025	8-K: Other Events
10 Nov 2025	8-K: Results of Operations and Financial Condition
22 Aug 2025	8-K: Regulation FD Disclosure
15 Aug 2025	8-K: Other Events
11 Aug 2025	8-K: Results of Operations and Financial Condition
04 Jun 2025	8-K: Regulation FD Disclosure

Comments